Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatic Perfusion Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00019760
What this trial is testing

Isolated Hepatic Perfusion With Melphalan Followed By Chemotherapy in Treating Patients With Unresectable Colorectal Cancer That is Metastatic to the Liver

Who this might be right for
Recurrent Colon CancerLiver MetastasesStage IV Rectal Cancer+2 more
National Institutes of Health Clinical Center (CC)
Post-approval studies (Phase 4)Study completedNCT02472249
What this trial is testing

Pharmacological Manipulation of Intrahepatic Arterial Blood Flow in HCC

Who this might be right for
Hepatocellular Carcinoma
University Health Network, Toronto 10
Large-scale testing (Phase 3)Study completedNCT01785316
What this trial is testing

The Scandinavian Randomized Controlled Trial of Isolated Hepatic Perfusion for Uveal Melanoma Liver Metastases

Who this might be right for
MelanomaUveal Neoplasms
Vastra Gotaland Region 93
Not applicableLooking for participantsNCT07492511
What this trial is testing

Renal and Hepatic Abnormal Doppler Patterns in Trauma

Who this might be right for
Trauma (Including Fractures)Trauma PatientsKidney Disease+3 more
Azienda Usl di Bologna 350
Not applicableStudy completedNCT05045794
What this trial is testing

Bridge to HOPE: Hypothermic Oxygenated Perfusion Versus Cold Storage Prior to Liver Transplantation

Who this might be right for
End Stage Liver DIseaseLiver Failure
Bridge to Life Ltd. 228
Early research (Phase 1)Study completedNCT00001587
What this trial is testing

A Phase I Study of Isolated Hepatic Portal and Arterial Perfusion (IHP) With Escalating Dose Melphalan for Primary or Metastatic Unresectable Cancers of the Liver

Who this might be right for
Liver NeoplasmsNeoplasm Metastasis
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Ended earlyNCT02415036
What this trial is testing

Melphalan for Use With the Hepatic Delivery System Treatment in Patients With Unresectable Hepatocellular Carcinoma or Intra Hepatic Cholangiocarcinoma

Who this might be right for
Hepatocellular CarcinomaIntrahepatic Cholangiocarcinoma
Delcath Systems Inc. 17
Not applicableStudy completedNCT04252794
What this trial is testing

Graft Inflow Modulation for Portal Hyper-perfusion in Live Donor Liver Transplantation

Who this might be right for
Cirrhosis, Liver
Institute of Liver and Biliary Sciences, India 75
Not applicableEnded earlyNCT01163526
What this trial is testing

Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic Malignancies

Who this might be right for
Neuroendocrine TumorsBrain (Nervous System) CancersColon/Rectal Cancer+4 more
Stanford University 13
Very early researchActive Not RecruitingNCT07519005
What this trial is testing

Ex Vivo Perfusion of Gene-Edited Porcine Livers in Patients With Severe Hepatic Failure

Who this might be right for
Hepatic Failure
Xijing Hospital 1
Not applicableStudy completedNCT02455115
What this trial is testing

Renal Perfusion, Filtration and Oxygenation After Liver Transplantation -Effects of av Postoperative Blood Pressure

Who this might be right for
Acute Kidney InjuryLiver Failure
Sahlgrenska University Hospital 12
Large-scale testing (Phase 3)Active Not RecruitingNCT05022901
What this trial is testing

An Open-Label Expanded Access Study of the Melphalan/Hepatic Delivery System (HDS) in Patients With Hepatic Dominant Ocular Melanoma

Who this might be right for
Metastatic Ocular MelanomaMetastatic Uveal Melanoma
Delcath Systems Inc. 30
Not applicableStudy completedNCT01499979
What this trial is testing

Hypothermic Perfusion During Hemihepatectomy

Who this might be right for
Hepatic Ischemia-reperfusion Injury
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 22
Not applicableStudy completedNCT07075562
What this trial is testing

TACE Plus Bevacizumab for Hepatocellular Carcinoma With Portal Vein Invasion

Who this might be right for
Hepatocellular Carcinoma (HCC)
The First Hospital of Hebei Medical University 180
Not applicableEnded earlyNCT00820456
What this trial is testing

Metastatic Colorectal Cancer: Treatment Response With Dynamic Contrast MRI

Who this might be right for
Colorectal NeoplasmHepatic Neoplasm
American College of Radiology 6
Large-scale testing (Phase 3)Looking for participantsNCT06519266
What this trial is testing

PHP in Combination With IPI1/NIVO3 Compared to IPI3/NIVO1 Only in Patients With Uveal Melanoma Liver Metastases

Who this might be right for
Uveal MelanomaLiver Metastases
Vastra Gotaland Region 40
Not applicableLooking for participantsNCT07585890
What this trial is testing

Establishing a Reference Framework for Outcomes After Machine-Preserved Liver Transplantation in Europe

Who this might be right for
End-stage Liver Disease (ESLD)Acute Liver FailureLiver Cirrhosis+1 more
University Medical Center Groningen 10,000
Large-scale testing (Phase 3)Study completedNCT00020501
What this trial is testing

Chemotherapy With or Without Isolated Hepatic Perfusion With Melphalan in Treating Patients With Colorectal Cancer That Has Spread to the Liver

Who this might be right for
Colorectal CancerMetastatic Cancer
National Institutes of Health Clinical Center (CC)
Not applicableEnrolling By InvitationNCT07578441
What this trial is testing

VitaSmart HOPE System: Bridge to HOPE Registry

Who this might be right for
End Stage Liver DIseaseLiver Failure
Bridge to Life Ltd. 5,000
Testing effectiveness (Phase 2)Temporarily pausedNCT06405061
What this trial is testing

Evaluation of Effectiveness and Safety of HAIC in Combination With Adebrelimab and Bevacizumab for Potentially Resectable Hepatocellular Carcinoma

Who this might be right for
AdebrelimabHepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 40
Next Page